Speaker illustration

Professor George Dangas

Mount Sinai Medical Center, New York (United States of America)

Member of:

European Society of Cardiology

Professor of Medicine (Cardiology) & Surgery (Vascular) @ Icahn School of Medicine, Assoc. Director of Mt Sinai Heart, Director, CV Innovation at Mt Sinai Hospital, NYC and Chief of Cardiology, MSQ; TCT Director, Interventional Cardiology Textbook Editor (3rd Edition, Wiley, UK). After his studies at the University of Athens, served as Medical Officer, Hellenic Navy. He trained in Medicine @Brown University, and Cardiology&Interventional @Mount Sinai. Among the 5 founding physicians of Cardiovascular Research Foundation NYC, he was faculty @Lenox Hill & Columbia University Medical Center; he led establishment of Interventional Fellowship Programs in both. He was Trustee of ACC & SCAI, Fellow of ESC & AHA, founder of ACC Interventional Council/Section & Cardiology Chair at Onassis Heart Center. He is President-Elect & Master of SCAI, Chair of AHA Laennec & Interventional Committees, JACC Section Editor, ACC Distinguished Fellow 2019 & Teacher 2017 & in Top/Super MD & WHOisWHO lists.

Antithrombotic therapy after TAVI

Event: ESC Congress 2021 - The Digital Experience

Topic: Interventional Cardiology

Session type: Symposium

Thumbnail

How innovative percutaneous Ventricular Assist Device (pVAD) systems improve outcomes in cardiogenic shock and facilitate complete revascularization in high risk Percutaneous Coronary Intervention (PCI) patients

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Miscellaneous

Session type: Satellite Symposium

Thumbnail

Acute hemodynamic support for impending, established cardiogenic shock & high risk PCI

Event: ESC CONGRESS 2016

Topic: Ventricular function / haemodynamics

Session type: Satellite Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk